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| INTRODUCTION
Chronic diseases (CDs) are increasingly prevalent and contribute significantly to the financial burden of health care.
1 Patient recall and understanding of pharmacological and lifestyle treatment information received during encounters are key intermediate variables towards better adherence, CD management and improved health outcomes.
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Unfortunately, recall is often faulty. Patients remember as little as a fifth of information discussed and immediately forget 40%-80% of the content of their medical encounters. 6, 11, 12 Factors influencing recall cited in the literature can be classified into three categories: (i) patient, (ii) information and (iii) communication. Patient characteristics include age, 6, 12, 13 education, health literacy 6, 12, [14] [15] [16] and anxiety. 6, 17, 18 Information characteristics include modality (written vs aural), 6, [19] [20] [21] structure, 11, [22] [23] [24] [25] number of instructions given 14, 26, 27 and encounter length. 13 Clinicians' communication skills are also related to recall. 3, 6, 28, 29 Few studies have examined the effect of patients' communication skills on their recall of information.
Authors stress the importance of activating patients, [30] [31] [32] [33] [34] especially those suffering from chronic diseases. 35, 36 A few studies aiming to increase patient participation have shown benefits in terms of recall. [37] [38] [39] [40] [41] However, the definition of patient participation is unclear.
Many studies equate patient participation with patient question asking. 5 , 40 The effect of question asking on recall of information remains equivocal; some studies show no effects, 13, 27, 39, 41 and others show positive effects 38 or even negative effects. 13, 27, 42 The main objectives of this study were to describe recall of 
| Study design
This study is an observational study within a randomized trial. The clinical trial, NCT00879736, was registered with ClinicalTrials.gov, and the protocol received ethics approval from the Institutional Review Board Services (IRB). Informed consent was obtained from physicians and patients. All participants were informed about the confidentiality of their data. There were no transcriptions of audiotapes. All direct identifying information was numerically coded.
The clinical trial was a three-arm parallel design that randomized patients into receiving one of the two communication interventions or usual care. Interventions were delivered either through the web only or combined with a workshop. The main objective was to assess the impact of the educational interventions compared to usual care (no additional material) on doctor-patient communication. Analysing group effects for medication information recall was not possible because of the quantity of missing data. Thus, this study disregarded original group assignment and reports on patients' correct recall of information about their chronic disease treatments.
| Setting and participants
Patients were recruited from nine urban and suburban communitybased PC practices in Ontario (Canada) between March and December 2009, by the study coordinator. The last outcome data were retrieved from patient charts in September 2010.
Participating family physicians (FPs) were chosen using a convenience sample and were considered eligible if they had been in practice at least 5 years, had a practice orientation towards an adult population, including chronic disease patients, agreed to the audio recording of one visit per participating patient. Once physicians consented, patients were approached by the study coordinator and enrolled if they consented and met the following criteria: (i) 40 years or more of age, (ii) ability to speak English, (iii) comfortable using a computer for routine activities such as regular access to the web and e-mail, (iv) have a routine follow-up visit scheduled within 3-4 months of study enrolment, (v) allow access to their medical records and (vi)
have at least one of the following three CDs: hypertension, type II diabetes and/or dyslipidaemia. These CDs were diagnosed by their physicians as not meeting treatment targets set by relevant Canadian guidelines. [44] [45] [46] Pregnant patients or those actively treated for cancer were excluded.
| Procedures
Patients were recruited and enrolled at an initial visit. Participating FP completed a basic socio-demographic and practice profile questionnaire at study enrolment. Patients meeting inclusion criteria completed a baseline questionnaire including socio-demographic and clinical data such as length of FP-patient relationship. 47 Three to four months later, they returned for their follow-up visit with their FP following normal scheduling. This visit was audio-recorded. Immediately following this visit, patients completed a questionnaire that assessed their recall of treatment information they had just discussed with their FP.
| Variables & measures
Predictor and outcome variables that were used in analyses and their sources are described in Table 1 .
Audio-taped encounters were coded with the Roter Interaction Analysis System (RIAS) 48 and MEDICODE. 49, 50 These two validated coding systems and the following measures are described in detail in Lussier et al. 43 
| Recall of treatment information
Immediately following the encounter, patients completed the postvisit questionnaire. They were asked whether they had discussed hypertension, diabetes or dyslipidaemia, and if so to elicit the name of all the medications they remembered discussing for each CD. Patients were also asked whether they had discussed the five other medica- 
| Statistical analyses
Baseline characteristics and descriptive statistics were analysed using chi-square tests and ANOVAs. A linear mixed model was performed to see what variables predicted recall of medication information.
Medication was the unit of analysis clustered within patients. The dependent variable was the combined score of recall of medication information. Variables theoretically related to recall in Table 1 were tested in univariate analyses. Variables significantly related to recall in univariate regressions (P<.15) were inserted into the final multivariate regression as fixed effects. All tests used an alpha level of significance of .05.
The sample size used here was based on participants from a randomized control trial (n=221). 43 Analyses concerning medication informa- 
| RESULTS

| Socio-demographic and clinical characteristics
A description of the randomization process for the original sample is reported in the primary paper. 43 
| Recall of chronic medical conditions and lifestyle treatment discussions
Recall of whether participants discussed hypertension, diabetes and cholesterol is shown in Table 3 . Hypertension, diabetes and cholesterol were discussed in 83.0% (n=183), 60.1% (n=133) and 50.2%
(n=111) of the 221 interviews, respectively. Patients recalled approximately 88% of these discussions. Recall of lifestyle treatment is also shown in Table 3 . Discussions of stress management, tobacco and alcohol reduction were rare; however, we do not have information allowing us to evaluate the relevance of these discussions (ie known smoking status). Diet and exercise were discussed in about half of the encounters. Recall of these discussions ranged from 42.8% (alcohol) to 70.0% (exercise).
[Colour figure can be viewed at wileyonlinelibrary.com]
Assessed for eligibility (n = 532) Excluded (n = 210) Not meeting inclusion criteria (n = 141) 54 
| Recall of chronic disease medication (CDM) information
The 159 participants analysed for medication discussions discussed a total of 401 chronic disease medications (CDMs). Descriptive statistics regarding medication discussions are shown in Table 4 . The majority of medications discussed during the encounter were of two main statuses, either actively being taken or represcribed, consistent with a CD population. Discussions were mostly initiated by physicians and had a low dialogue score. Medication discussions were not extensive in terms of the number of themes discussed. The most often T A B L E 2 Socio-demographic, clinical and encounter characteristics at baseline for 159 patients included in the medication recall analyses *Some patients were enrolled for more than one diagnosis, so percentages do not equal 100%.
T discussed theme besides the name was instructions, mentioned in less than half of the medication discussions. 
| DISCUSSION
Recall is an important mediating variable for improved treatment adherence and health outcomes. 4, 6, 11 This study focused on recall of both lifestyle and pharmacologic treatment information deemed crucial for the optimal management of CD. One of the strengths of this study is its focus on long-standing CD patients followed in PC and not reaching guideline-suggested outcomes. Recall was assessed immediately after the medical encounter.
F I G U R E 2
Recall of medication information, no. (%) (n=401 medication discussions, from n=159 interviews)*. X-axis: medication theme. The Y axis denotes the Frequency of theme discussions out of the 401 medication discussions coded with MEDICODE, see Table 4 . Green bars are the proportion of patients with Correct recall of the information discussed. Full red bars are patients' Incorrect recall of information when they were able to elicit the medication name. Patterned red bars correspond to the situation in which patients could not name the Medication discussed in the encounter and thus not indicate discussion of other themes. Patterned red bars are considered incorrect recall. Initiative scores go from −1 (patient initiative) to 1 (physician initiated).
F I G U R E 3 Frequency distribution of medication theme recall. X-axis: Number of themes correctly recalled. Y-axis: Instances of theme recall T A B L E 5 Linear Mixed Model for variables influencing correct medication information recall
| Type of recall measure
The heterogeneity of recall measurements has been recognized and has a major impact on the evaluation of recall. 11, 12, 52 The results of our study confirm this. Correct recall of treatment information in this sample ranged from <34% to 88% depending on what was being recalled and how recall was measured. This range is consistent with the bulk of published research. 6, 11, 12, 19, 38, [52] [53] [54] [55] Recall was high for a general question such as remembering discussing hypertension. However, recall of specific discussions, such as exercise and diet in relation to the CD, dropped respectively to 70% and only 50% of patients remembering discussing these issues.
Recall scores are higher for yes-no or multiple-choice-type questions, than for open-ended questions asking patients to elicit information. 56 This has been replicated in our study, where eliciting the medication name had lower recall scores than yes-no questions regarding either specific medication themes or lifestyle issues. Considering that yes-no questions are more easily answered than open-ended questions, it is of potential concern that only half of patients remember whether or not they discussed diet. This makes one wonder how many would be able to remember specific elements of their diet discussion so important in the management of the three CDs this study focused on.
| Recall of medication information
For medication information, the recall score used here was relatively strict, because patients who did not recall medication names were automatically given a score of zero for the other themes. This way of scoring recall may in fact underestimate level of theme medication recall; however, questions were still yes-no as described above. Patients correctly remembered discussing one medication theme, when 2.5 themes were discussed on average. Patients were able to elicit less than half of the names of medications that they had just discussed with their providers. Medication names are frequently the best recalled items. 22, 24, 53, 57 A common concept throughout history and across cultures is the idea that knowing the name of something gives one power over it. 58 Naming, thinking and apprehending reality are intimately related. 59 Medication names are an important way to establish shared language between patients and physicians and are instrumental in empowering patients to reflect upon, understand and manage their health.
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Discussions of the six themes deemed most important for a patient with CD to properly take and adhere to their medication do not occur frequently. Less than half of medication discussions include instructions about how to take medications, and adherence is mentioned in only about a fifth of discussions. Although it is possible that FPs did not deem necessary to repeat instructions in these actively taken or represcribed medications, this is questionable considering these patients were not at target. Furthermore, patients only remember about a third of these discussions when they actually do take place.
Although concordant with the literature, the low recall scores of medication information are concerning considering the characteristics of our sample. These patients with CD were off target and in longterm relationships with their FPs. These are precisely the patients who need to be mobilized to properly manage their own care. Patients were generally discussing medications that they were actively taking. Many patients did not even discuss CD medications (47/221) during the audio-taped follow-up appointment. These patients were older than the rest of our sample, and it is troubling to see that medication discussions may be eschewed in older patients. Admittedly, one encounter does not capture continuous care. Yet, considering the low rate of recall, discussing relevant medications at each consultation would seem indicated for off-target CD populations.
| Patient participation and medication information recall
Beyond describing recall of treatment information, an aim of this study was to assess which communication and patient participation variables predict medication information recall. There is a need in the literature to be clear about how we define patient participation. 5, 63 In this study, we used two different coding systems with different underlying assumptions about patient participation. RIAS is an interaction-based coding system. It codes each physician and patient speech act into two metacategories: instrumental and socio-emotional. Each speech act is then assigned to a large content domain such as medical condition, treatment, lifestyle or psychosocial. Participation is classically conceptualized in this system as an aggregate of different types of physician and patient utterances, such as physician dominance and communication control, describing a general pattern unrelated to specific content. Participation can also be defined, as we have done in this study, as PACE-like interactions reflecting specific information-seeking and clarification behaviours. MEDICODE, on the other hand, is a contentbased coding system. It first codes for specific content such as medication name, instructions, main effects. Each content element identified is then described in terms of interaction: who, of the two interlocutors, initiated the content, and how much dialogue occurred for that specific theme. Thus, measurement of participation in this second coding system is intimately linked to specific content discussions.
RIAS scores of socio-emotional utterances, physician dominance, communication control and the PACE score, measuring "ask", "check"
and "express" utterances, were not found to be predictors of patient recall. It is possible that these patient participation measures were not predictors of patient recall because RIAS participation scores reflect a more "global" measure of the whole encounter. This does not capture the subtle variations of patient participation in specific discussions of medications. 50 It is possible to look at RIAS measures in the light of Giddens' theory of practical and discursive consciousness. RIAS measures, because they reflect interactional styles and processes, can be seen as belonging to the order of practical consciousness. Practical consciousness is knowledge that is inherent in everyday actions, often unnoticed. Talking in a socio-emotional way is something that patients and physicians do, without always realizing they are doing it. Discursive consciousness reflects knowledge that is verbalized and is thus often better remembered. Content that has been coded by MEDICODE, for example, can be associated with discursive consciousness and may be more easily remembered.
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In this study, greater patient initiative and greater dialogue about medications, measured with MEDICODE, were predictors of patient recall. A known cognitive phenomenon, the "generation effect," stipulates that active involvement in producing information improves recall compared to passive reception. 65 Authors suggest that this effect may be due to an egocentric bias and a more accurate monitoring of one's contributions to the production of content. [66] [67] [68] [69] When there is patient initiative and dialogue, patients produce information and are actively involved in the discussion. This finding lends importance to developing skills in improved information exchange. 70 Unfortunately, providers infrequently use recall-promoting techniques that aim to involve the patient, such as "teach-back". 10, 54, 71 Our sample of patients with CD who were familiar with their FPs benefited from greater extent of information, replicating findings from other studies. The more medication themes were discussed, the better patients recalled medication information. Other studies have found information provision to be an important predictor of recall. 27, 42 However, too much information can overwhelm patients, 23, 26, 55 an effect that may be mitigated by an established relationship with FPs.
Discussing multiple themes surrounding a treatment deepens and adds density to the conversation. This extensive approach to the discussion can enable more conscious involvement.
Of note, new medication prescriptions were better recalled than active prescriptions, which may explain why Tarn et al. 
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Despite the above noted importance of information provision, medication discussions were often not extensive. Themes that help patients understand what their medications are and why they should be taking them 51, 62 are seldom discussed. Shared decision making is hailed as the future of medical consultations. However, there cannot be any shared decision making if there is not a sufficient information exchange.
Street has described three ways of assessing the quality of information exchanges. One is through message properties, such as the content and form of communication. One is through the process of co-construction of messages, and the third is through the outcomes of the information exchange. 73 We have included all three ways of measuring this information exchange, using RIAS and MEDICODE to assess the content and form, using dialogue and initiative scores to assess co-construction and by assessing recall as the outcome of the information exchange. This study shows the importance of having an information exchange that covers essential information about medications. Furthermore, information cannot simply be passively transmitted, as a physician initiated monologue, but needs to be co-constructed with the patient.
| Generalizability
This study had a heterogeneous multimorbid CD patient sample in long-term relationships with their FPs. This sample is typical of the adult primary care patient population, compared to most studies, which only focus on single diseases, such as diabetes. We are confident that the observations reported are generalizable to communitybased family physicians. Firstly, physicians were given no instructions beyond the fact that they were participating in a communication study. Their interview schedules were not modified for the study, and the average length of encounters was comparable to Ontario average PC visit lengths. Perhaps less generalizable to this population is the criterion of computer literacy. However, computer literacy is rapidly increasing in age groups of 55-64, where more than 70% of users access the Internet. 
| Limitations
This study has several limitations. Firstly, a selection bias cannot be excluded. Participants were chosen according to eligibility criteria for the randomized controlled trial that was being conducted. Furthermore, 62 patients from the original sample (n=221) 43 were excluded from analyses because they did not discuss CDMs (n=47) or CDMs were not identifiable (n=15). Despite participant loss, most baseline factors remained equivalent. This study is not exempt from a possible
Hawthorne effect because consultations were audio-taped. However, studies have shown that the Hawthorne effect is negligible in doctorpatient communication research. [75] [76] [77] [78] In addition, it is possible that this study suffers from misclassification bias. The score used to assess recall was strict and was dependent on a questionnaire that was specifically developed for this study. Questionnaires used to assess recall are often not validated, and further research would benefit from the validation of a measure designed to assess treatment information recall. 
| CONCLUSION & PRACTICE IMPLICATIONS
The aims of this study were to describe treatment information recall and to assess which communication and patient participation variables are related to medication information recall for off-target CD patients. Providers cannot take for granted that long-term off-target CD patients know and remember treatment information. This is particularly relevant considering the ageing demographics of PC populations. Elderly patients were less likely to discuss their CD medications and had poorer recall when they did. Further research is needed to understand the dynamics between ageing patients, medication discussions and recall. There is a lack of shared language and empowerment in managing one's disease. Encounters with patients with CD need to engage in an explicit conversation about relevant lifestyle modifications and medications. 70 This conversation should ideally be thorough and engage patients in a true dialogue. Providers and patients need to engage more frequently about treatment information in ways that encourage patients to be active participants in the discussion. Improved discussions may impact treatment information recall. This is an important step towards improved self-management, adherence and eventually better health outcomes.
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